LTBI Clinical Recommendations
- A new update to the Testing and Treatment of Latent Tuberculosis Infection in the United states: A Clinical Guide for Health Care Providers and Public Health Programs, Third...
- The updated LTBI Clinical Guide is available as a free PDF download.
- Stay informed about future revisions by providing your email address to receive update notifications.
Updated Clinical Guide for Latent Tuberculosis Infection (LTBI) released
Table of Contents
- Updated Clinical Guide for Latent Tuberculosis Infection (LTBI) released
- Updated Clinical Guide for Latent Tuberculosis Infection (LTBI): your Questions Answered
- What is the LTBI Clinical Guide?
- Where Can I Download the Updated LTBI Clinical Guide?
- Why Should I Download and Use this Guide?
- What are the Key Features of the LTBI Clinical Guide?
- Who is the Target Audience for the LTBI Clinical Guide?
- What Topics are Covered in the Clinical Guide?
- What additional Resources are Included in the Appendices?
- How Has the Guide Been Updated Over Time?
- Will the Guide Continue to be Updated?
- Key Updates and focus Areas in the LTBI Clinical Guide
- What is the Disclaimer Regarding the Use of This Guide?
A new update to the Testing and Treatment of Latent Tuberculosis Infection in the United states: A Clinical Guide for Health Care Providers and Public Health Programs, Third Edition, has been released in February 2025, addressing several grammatical issues to improve clarity and usability.
Accessing the Updated LTBI Clinical Guide
The updated LTBI Clinical Guide is available as a free PDF download. It is recommended to register upon downloading to track interest and receive alerts about future updates,as the guide is intended to be a ”living document” that evolves with new scientific findings and best practices.
Stay informed about future revisions by providing your email address to receive update notifications.
Background on the Clinical Guide
This updated clinical guide on latent tuberculosis infection (LTBI) serves as a practical reference for healthcare providers. It supports the implementation of the 2020 “Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC.”
Key Features of the LTBI Clinical Guide
The Clinical Guide aims to:
- Translate the clinical advances of the 2020 guidelines into practical strategies for patient care, covering screening, testing, treatment decisions, and treatment completion.
- Emphasize a patient-centered approach to LTBI management.
- Present current perspectives from TB clinicians on managing clinically complex cases.
Target Audience
This document is designed for healthcare providers in various settings, including:
- Public health departments and TB programs
- Community clinics
- Hospitals
- Private medical practices
- Congregate facilities (e.g.,long-term care,homeless shelters,correctional facilities)
Comprehensive Contents
The Clinical Guide offers a comprehensive overview of LTBI,addressing essential topics identified thru expert input and practical experience. Key areas covered include:
- Immunologic Tests for TB Infection
- When to Test for LTBI
- Pretreatment Clinical Evaluation
- Deciding Whether to Treat and Choosing a regimen
- Considerations for Specific Populations
- Monitoring and Managing Treatment
- Nurse Case Management (brief overview)
The appendices provide additional resources, such as TB test interpretation, information on drugs used to treat LTBI, treatment regimen dosages, guidance on collaborations between public health and community service providers, and details on directly observed therapy and video observed therapy.
Updates and Revisions
The second edition incorporated a review of current literature and feedback from users of the first edition. Updates included information on LTBI treatment during pregnancy, guidance from the American Academy of Pediatrics on using IGRAs in children, TB screening before and during immunosuppressive therapies, LTBI treatment in patients with kidney disease, and updated references.
Additions to the second edition featured guidance for patients traveling outside the United States, the use of rifabutin monotherapy in patients with HIV, second-round testing and follow-up for children and recent contacts in contact investigations, and treatment of immunosuppressed close contacts. The second edition also clarified the appropriate use of isoniazid in patients with baseline liver disease and when baseline laboratory testing is warranted.
The third edition addresses the use of the 1HP regimen in individuals with and without HIV. The August 2024 update to the third edition incorporated 2024 guidance on IGRAs issued by the American Academy of Pediatrics. The February 2025 update specifically corrected grammatical issues.
As a “living document,” the guide will continue to be updated as new information emerges regarding LTBI testing and treatment. For topics with ongoing developments, such as COVID-19-TB testing and nitrosamine concerns, the document will link to regularly updated resources.
Additional Resources for Testing and Treating LTBI
disclaimer
This Clinical Guide is intended to assist clinicians and healthcare professionals in making informed decisions regarding latent tuberculosis screening, diagnosis, and treatment. It should be used as a tool to support clinical judgment, not replace it. The full disclaimer is available within the publication.
Updated Clinical Guide for Latent Tuberculosis Infection (LTBI): your Questions Answered
A newly updated Clinical Guide for Health Care Providers and Public Health Programs, third Edition has been released in February 2025, focusing on latent tuberculosis infection (LTBI). This Q&A-style article addresses common questions about the guide, its contents, and its implications for healthcare professionals.
What is the LTBI Clinical Guide?
The Clinical Guide is a practical reference designed to assist healthcare providers in the United States with the screening, diagnosis, and treatment of latent tuberculosis infection (LTBI). The third edition, updated in February 2025, includes the latest recommendations and best practices. The guide is intended to be a “living document” and is updated as new information emerges.